Antibiofilm activity of

Biofilm Cystic fibrosis Interspecies interactions Lung microbiota Pseudomonas aeruginosa

Journal

Biofilm
ISSN: 2590-2075
Titre abrégé: Biofilm
Pays: Netherlands
ID NLM: 101764202

Informations de publication

Date de publication:
Jun 2024
Historique:
received: 24 01 2024
revised: 06 05 2024
accepted: 06 06 2024
medline: 8 7 2024
pubmed: 8 7 2024
entrez: 8 7 2024
Statut: epublish

Résumé

It is increasingly recognized that interspecies interactions may modulate the pathogenicity of

Identifiants

DOI: 10.1016/j.bioflm.2024.100206 PMID: 38975276 PMC: PMC11225020
pubmed: 38975276
doi: 10.1016/j.bioflm.2024.100206
pii: S2590-2075(24)00031-5
pmc: PMC11225020
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100206

Informations de copyright

© 2024 The Authors.

Déclaration de conflit d'intérêts

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Aurelie Crabbe reports financial support was provided by Ghent University Special Research Fund (BOF/STA/201909/028) and by the Fund Alphonse and Jean Forton of the Kind Baudouin Foundation and the Belgian Cystic Fibrosis Association (2023-J1810150-232649). Lucia Grassi reports financial support was provided by Ghent University Special Research Fund (BOF.DPO.2019.023.01) and Research Foundation Flanders (FWO) (12X6322N). Tom Coenye is senior editor of the journal ‘Biofilm’. All other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Lucia Grassi (L)

Laboratory of Pharmaceutical Microbiology, Ghent University, Ghent, Belgium.

Kyle L Asfahl (KL)

Department of Microbiology, University of Washington, Seattle, WA, USA.

Sara Van den Bossche (S)

Laboratory of Pharmaceutical Microbiology, Ghent University, Ghent, Belgium.

Ine Maenhout (I)

Laboratory of Pharmaceutical Microbiology, Ghent University, Ghent, Belgium.

Andrea Sass (A)

Laboratory of Pharmaceutical Microbiology, Ghent University, Ghent, Belgium.

Yannick Vande Weygaerde (Y)

Cystic Fibrosis Reference Centre, Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.

Eva Van Braeckel (E)

Cystic Fibrosis Reference Centre, Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
Department of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium.

Bruno Verhasselt (B)

Laboratory of Medical Microbiology, Ghent University Hospital, Ghent, Belgium.
Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.

Jerina Boelens (J)

Laboratory of Medical Microbiology, Ghent University Hospital, Ghent, Belgium.
Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.

Michael M Tunney (MM)

School of Pharmacy, Queen's University Belfast, Belfast, Northern Ireland, UK.

Ajai A Dandekar (AA)

Department of Microbiology, University of Washington, Seattle, WA, USA.

Tom Coenye (T)

Laboratory of Pharmaceutical Microbiology, Ghent University, Ghent, Belgium.

Aurélie Crabbé (A)

Laboratory of Pharmaceutical Microbiology, Ghent University, Ghent, Belgium.

Classifications MeSH